Project Details
Description
PER CASE REIMBURSEMENT: COG AALL2121 Syndax Pharmaceuticals, Inc.
| Status | Active |
|---|---|
| Effective start/end date | 11/1/23 → 10/31/25 |
Funding
- PUBLIC HEALTH INSTITUTE
- SYNDAX PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.